细胞外囊泡作为下一代药物输送平台,用于类风湿性关节炎治疗
Yi Jin1, Cong Xu2, Yujuan Zhu1
1Department of Rheumatology, Research Center of Clinical Medicine, Research Center of Immunology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
概括
细胞外囊泡 (EVs) 通过有效地提供疗法来治疗类风湿性关节炎 (RA) 是有前途的. 这些天然载体为先进的RA治疗提供了诸如生物相容性和降低免疫反应等优势.
科学领域:
- 免疫学和风湿病学
- 生物技术和纳米医学
背景情况:
- 类风湿性关节炎 (RA) 是一种全身性自身免疫性疾病,导致慢性炎症和结缔组织损伤.
- 目前的RA治疗面临着针对性交付和管理自身免疫破坏的挑战,导致潜在的残疾.
- 细胞外囊泡 (EVs) 正因其生物相容性和低免疫性而成为一个有前途的治疗平台.
研究的目的:
- 审查类风湿性关节炎的发病机制和当前的治疗策略.
- 探索细胞外囊泡 (EVs) 作为RA治疗药物输送系统的潜力.
- 讨论RA治疗中基于EV的治疗方法的进展,挑战和未来方向.
主要方法:
- 关于RA发病的综合文献综述,当前的治疗方法和EV生物学.
- 分析EV特性,包括生物相容性,体内半衰期和免疫性.
- 对基于EV的RA药物输送系统的最近研究的评估.
主要成果:
- 电动车在药物输送方面具有自然优势,包括逃避细胞分裂和最大限度地降低治疗剂的免疫性.
- 在临床前模型中,EV已经显示出有针对性交付和RA治疗效果的潜力.
- 显著的技术创新正在推进EV研究,用于RA的临床应用.
结论:
- 细胞外囊泡代表了对类风湿性关节炎药物输送的重大进步.
- 基于EV的治疗方法有可能彻底改变RA治疗策略.
- 进一步的研究和技术开发对于将EV平台转化为RA的临床实践至关重要.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
602
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
9.3K
相关概念视频
Drug Delivery: Miscellaneous Routes
299
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
299
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
